Dashboard MRSA
Repurposing candidates for MRSA
Methicillin-resistant Staphylococcus aureus
Approved medicines with AI-predicted activity ≥40% against MRSA, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 860
- Existing antimicrobials set aside
- 117
- Needing review
- 72
- Repurposing candidates
- 671
Repurposing candidates for MRSA
AI prediction · nothing measuredAll 671 repurposing candidates for MRSA.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- RoflumilastExisting use: Airway obstruction, Chronic bronchitis, Chronic obstructive pulmonary disease and 1 more53.9% AI-predicted activityagainst MRSA50+ registered studies
- BaricitinibExisting use: Rheumatoid arthritis53.9% AI-predicted activityagainst MRSA50+ registered studies
- Metocurine IodideExisting use: Curare alkaloids53.8% AI-predicted activityagainst MRSANo documented evidence found
- Paramethasone AcetateExisting use: Glucocorticoids53.8% AI-predicted activityagainst MRSANo documented evidence found
- Mivacurium ChlorideExisting use: Other quaternary ammonium compounds53.8% AI-predicted activityagainst MRSA14 registered studies
- HalazepamExisting use: Anxiety53.6% AI-predicted activityagainst MRSANo documented evidence found
- OmaveloxoloneExisting use: Friedreich ataxia53.6% AI-predicted activityagainst MRSA25 registered studies
- Topotecan HydrochlorideExisting use: Carcinoma, Cervical adenocarcinoma, Cervical cancer and 5 more53.6% AI-predicted activityagainst MRSA50+ registered studies
- DesonideExisting use: Atopic eczema, Eye inflammation, Skin disease53.5% AI-predicted activityagainst MRSA13 registered studies
- Dabigatran Etexilate MesylateExisting use: Atrial fibrillation, Deep vein thrombosis, Pulmonary embolism and 5 more53.5% AI-predicted activityagainst MRSA14 registered studies
- Triamcinolone DiacetateExisting use: Airway obstruction, Eye inflammation, Hemorrhoid and 2 more53.5% AI-predicted activityagainst MRSA50+ registered studies
- CapivasertibExisting use: Breast cancer, Breast neoplasm, Cancer and 1 more53.4% AI-predicted activityagainst MRSA50+ registered studies
- Vecuronium BromideExisting use: Other quaternary ammonium compounds53.3% AI-predicted activityagainst MRSA50+ registered studies
- DarolutamideExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 4 more53.3% AI-predicted activityagainst MRSA50+ registered studies
- Loteprednol EtabonateExisting use: Allergic conjunctivitis, Anterior uveitis, Dry eye syndrome and 2 more53.2% AI-predicted activityagainst MRSA50+ registered studies
- TipranavirExisting use: Hemorrhage, HIV infection, Viral disease53.2% AI-predicted activityagainst MRSA50+ registered studies
- PimozideExisting use: Psychosis, Tics, Tourette syndrome53.2% AI-predicted activityagainst MRSA15 registered studies
- Triamcinolone HexacetonideExisting use: Airway obstruction, Eye inflammation, Hemorrhoid and 3 more53.1% AI-predicted activityagainst MRSA50+ registered studies
- Daridorexant HydrochlorideExisting use: Insomnia53.1% AI-predicted activityagainst MRSA2 registered studies
- Tafenoquine SuccinateExisting use: Malaria, Plasmodium vivax malaria53.1% AI-predicted activityagainst MRSA42 registered studies
- Lenvatinib MesylateExisting use: Cancer, Neoplasm, Papillary thyroid carcinoma and 4 more53.0% AI-predicted activityagainst MRSA23 registered studies
- ZanubrutinibExisting use: Cancer, Mantle cell lymphoma, Neoplasm and 1 more53.0% AI-predicted activityagainst MRSA50+ registered studies
- Ritlecitinib TosylateExisting use: Alopecia areata52.8% AI-predicted activityagainst MRSA1 registered study
- Raloxifene HydrochlorideExisting use: Breast cancer, Osteoporosis, Postmenopausal osteoporosis52.7% AI-predicted activityagainst MRSA50+ registered studies